Intramuscular stimulation lead with enhanced infection...

A - Human Necessities – 61 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61N 1/05 (2006.01)

Patent

CA 2189713

To minimize the incidence and consequences of device related infection that occur after prosthetics implants of neuro-muscular stimulating devices, an infection resistant intra-muscular lead has been developed and is disclosed herein. Infection incidence has been decreased by using biomaterials able to release antibacterial drugs (gentamicin) at a controlled rate for the first 3-6 weeks after implant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Intramuscular stimulation lead with enhanced infection... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Intramuscular stimulation lead with enhanced infection..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intramuscular stimulation lead with enhanced infection... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2048784

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.